SEATTLE–(BUSINESS WIRE)–LumiThera Inc., azienda di dispositivi medici che offre trattamenti di fotobiomodulazione (PBM) per danni e malattie oculari, ha annunciato oggi un aggiornamento sullo stato normativo del Valeda® Light Delivery System. A segui…
Category: Business
LumiThera fait une mise à jour de l'examen sur le traitement du Valeda par la FDA pour les patients atteints de DMLA sèche
SEATTLE–(BUSINESS WIRE)–LumiThera Inc. est une entreprise de dispositifs médicaux qui propose un traitement des lésions et des maladies oculaires par photobiomodulation (PBM) a annoncé aujourd’hui une mise à jour du statut réglementaire du système de…
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
GENEVA–(BUSINESS WIRE)–Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
GENEVA–(BUSINESS WIRE)–Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference
Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced positive top-line res…
EyeSouth Partners Affiliates With Atlantic Eye Institute, Representing The Network’s 39th Affiliation and Ninth in Florida
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is excited to announce that it has partnered with Atlantic Eye Institute, representing its ninth affiliation in Florida and 39th affiliation overall. EyeSouth is an eye care-focu…
Riassunto: Nordic Pharma Group B.V. completa, tramite la propria affiliata Amring Pharmaceuticals Inc., l’acquisizione di Visant Medical finalizzata al lancio di un’innovativa terapia della sindrome dell’occhio secco negli Stati Uniti
BERWYN, Pennsylvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), un’affiliata di Nordic Group B.V. (Nordic Pharma), oggi ha annunciato di avere completato l’acquisizione di Visant Medical, Inc. (Visant), un leader nell’innovazione medico-te…
Resumen: Nordic Pharma Group B.V., con su filial Amring Pharmaceuticals Inc., cierra la adquisición de Visant Medical para presentar un tratamiento novedoso contra la sequedad ocular en Estados Unidos
BERWYN, Pensilvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), filial de Nordic Group B.V. (Nordic Pharma), ha anunciado hoy que se ha concretado la adquisición de Visant Medical, Inc. (Visant), líder en innovación de tecnología médica par…
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitis
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Tuesday, December 19, 2023, at 8:00 a.m. (ET) to provide top-line results from a Phase 2 clinical trial…
Samenvatting: Nordic Pharma Group B.V. rondt via haar dochteronderneming Amring Pharmaceuticals Inc. de overname af van Visant Medical en lanceert een nieuwe therapie voor droge-ogenziekte in de Verenigde Staten
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), een dochteronderneming van Nordic Group B.V. (Nordic Pharma), kondigde vandaag aan dat de overname van Visant Medical, Inc. (Visant) is afgerond. Visant Medical is een toonaangevend be…
Nordic Pharma Group B.V. schließt über ihre Tochtergesellschaft Amring Pharmaceuticals Inc. die Übernahme von Visant Medical ab, um in den Vereinigten Staaten eine neuartige Therapie für trockene Augen einzuführen
BERWYN, Pennsylvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), eine Tochtergesellschaft der Nordic Group B.V. (Nordic Pharma), gab heute den Abschluss der Übernahme von Visant Medical, Inc. (Visant) bekannt, einem Marktführer im Bereich d…
Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V. (Nordic Pharma), announces the completion of its acquisition of Visant Medical, Inc.
20/20 Onsite Expands ‘Vision for Boston’ Program to Provide Eye Care to More Schools
BOSTON–(BUSINESS WIRE)–For the fourth consecutive year, 20/20 Onsite, the leading provider of on-site vision care, is partnering with Boston Public Schools, the New England College of Optometry, and Warby Parker to provide vision screenings, eye exam…
Reviewed Returns to CES with Second Annual AccessABILITY Awards
MCLEAN, Va.–(BUSINESS WIRE)–Reviewed, USA TODAY’s consumer product review brand, part of Gannett Co., Inc. (NYSE: GCI) will host its second annual AccessABILITY Awards, honoring the top products designed for consumers with disabilities. Reviewed will…
Kopin Receives Additional $6 Million Order for Thermal Weapon Sight
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical solutions and high performance micro-displays for defense, enterprise, consumer and medical products, today announced it has recei…
Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced positive topline eff…
VISIE Inc., a Medtech Computer Vision and Spatial Computing Company, Joins NVIDIA Inception to Up Its Computing Power
AUSTIN, Texas–(BUSINESS WIRE)–VISIE Inc., formerly Advanced Scanners, today announced it has joined NVIDIA Inception, a program that empowers early-stage companies revolutionizing industries with technological advancements. VISIE is a medtech growth …
KeraLink International Launches the Great Cornea Challenge and a Cornea Technology Accelerator
BALTIMORE–(BUSINESS WIRE)–KeraLink International (KLI) today announced the launch of the Great Cornea Challenge and the Cornea Technology Accelerator. These bold initiatives are designed to attract and support innovators and entrepreneurs to help in …
Cincinnati Eye Institute, an EyeCare Partners Practice, Opens New CEI Retina Clinic at The Landings in Blue Ash
CINCINNATI–(BUSINESS WIRE)–EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, today announced the grand opening of its Cincinnati Eye Institute (CEI) Retina Clinic at The Landings in Blue Ash, furthering its comm…
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
UPPSALA, Sweden–(BUSINESS WIRE)–Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing high-quality purifi…